Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_assertion type Assertion NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_head.
- NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_assertion description "[Antibody (Ab)-positive pure red-cell aplasia (PRCA) is a very rare but serious adverse event associated with recombinant human erythropoietin treatment (4.1 reports per 100,000 patient-years) in which patients produce antibodies to recombinant and endogenous erythropoietin, halting red blood cell production.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_provenance.
- NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_assertion evidence source_evidence_literature NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_provenance.
- NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_assertion SIO_000772 18370845 NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_provenance.
- NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_assertion wasDerivedFrom befree-20140225 NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_provenance.
- NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_assertion wasGeneratedBy ECO_0000203 NP635907.RAU3hNXRailU4eeWGh1ceM65qoBqMwj0uI3EtYaBNDLsA130_provenance.